Anti-oxidant activity of 1-(1H-imidazo[4,5-c]pyridin-4-yl)ethenone, a Maillard reaction product derived from fructose and histidine

被引:0
|
作者
Zhao, Kangyu [1 ]
Long, Xin [1 ]
Li, Junle [1 ]
Wang, Ying [1 ]
Lan, Ping [1 ]
Wang, Yong [1 ]
机构
[1] Jinan Univ, Guangdong Joint Int Res Ctr Oilseed Biorefinery Nu, Dept Food Sci & Engn, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
antioxidant activity; fructose; histidine; Maillard reaction products; quantum chemical calculation; molecular docking; MODEL; INHIBITION;
D O I
10.1002/jsfa.13779
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
BACKGROUND: The Maillard reaction involves the interaction of various amino acids and reducing sugars, resulting in food browning. It often produces appealing aromas and flavors. The complexities of the reaction are such that it can be challenging to identify the often numerous and frequently volatile products formed by it. In the present study, we sought to identify and evaluate an unusual product with anti-oxidant activity arising from a fructose-histidine Maillard reaction model. The anti-oxidant profile of this product was assessed by computational means. RESULTS: The fructose-histidine Maillard reaction products (FH-MRPs) were generated by heating a 2:1 mixture of the sugar and the amino acid at 140 degrees C for 2 h. Chromatographically separable fractions, labelled DM-1 to DM-8, were obtained using silica gel as the stationary phase and dichloromethane/methanol (DCM/MeOH) mixtures as the mobile one. Fraction DM-5 exhibited the highest 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, and further bio-assay guided fractionation led to isolation and identification of 1-(1H-imidazo[4,5-c]pyridin-4-yl)ethenone (IMPE) as the active principal, the structure of which was established by nuclear magnetic resonance (NMR) spectroscopic and mass spectral techniques. A mechanism for the formation of IMPE from its precursors is proposed. Density functional theory (DFT) calculations suggest this novel heterocyclic compound exerts its anti-oxidant effects by interacting with DPPH and 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radicals. Essentially, IMPE was non-toxic below 300 ug mL(-1), showing a concentration-dependent free radical clearance capacity and reducing power within the 100-1000 mu g mL(-1) range, and moreover, exhibiting significant Fe2+ chelating abilities wihin the 50-200 mu g mL(-1) range. CONCLUSION: This study identified the unique FH-MRP, IMPE, and found that it acts as food antioxidant through the chelation of metal ions. (c) 2024 Society of Chemical Industry.
引用
收藏
页码:9548 / 9558
页数:11
相关论文
共 50 条
  • [41] 1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors' (vol 15, pg 3402, 2005)
    Bamford, Mark J.
    Alberti, Michael J.
    Bailey, Nicholas
    Davies, Susannah
    Dean, David K.
    Gaiba, Alessandra
    Garland, Stephen
    Harling, John D.
    Jung, David K.
    Panchal, Terence A.
    Parr, Christopher A.
    Steadman, Jon G.
    Takle, Andrew K.
    Townsend, James T.
    Wilson, David M.
    Witherington, Jason
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (05) : 1151 - 1151
  • [42] Structure-Activity Studies of 1H-Imidazo[4,5-c]quinolin-4-amine Derivatives as A3 Adenosine Receptor Positive Allosteric Modulators
    Fallot, Lucas B.
    Suresh, R. Rama
    Fisher, Courtney L.
    Salmaso, Veronica
    O'Connor, Robert D.
    Kaufman, Noy
    Gao, Zhan-Guo
    Auchampach, John A.
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (22) : 15238 - 15262
  • [43] Ring Transformation of 7-Nitro-1-(4-nitrophenyl)-4,5-dihydro-1H-imidazo- and -[1,2,3]triazolo[4,5-c]pyridin-4-ones
    Yu. M. Yutilov
    N. N. Smolyar
    A. B. Eres'ko
    S. V. Gres'ko
    Russian Journal of Organic Chemistry, 2004, 40 : 1015 - 1017
  • [44] Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor
    Goblyos, Aniko
    Gao, Zhan-Guo
    Brussee, Johannes
    Connestari, Roberto
    Santiago, Sabrina Neves
    Ye, Kai
    IJzerman, Adriaan P.
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) : 3354 - 3361
  • [45] STRUCTURE-ACTIVITY-RELATIONSHIPS OF ARYLIMIDAZOPYRIDINE CARDIOTONICS - DISCOVERY AND INOTROPIC ACTIVITY OF 2-[2-METHOXY-4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZO[4,5-C]PYRIDINE
    ROBERTSON, DW
    BEEDLE, EE
    KRUSHINSKI, JH
    POLLOCK, GD
    WILSON, H
    WYSS, VL
    HAYES, JS
    JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (06) : 717 - 727
  • [46] SYNTHESIS AND ANTICONVULSANT ACTIVITY OF 3H-IMIDAZO[4,5-C]PYRIDAZINE, 1H-IMIDAZO[4,5-D]PYRIDAZINE AND 1H-BENZIMIDAZOLE ANALOGS OF 9-(2-FLUOROBENZYL)-6-METHYLAMINO-9H-PURINE
    KELLEY, JL
    THOMPSON, JB
    STYLES, VL
    SOROKO, FE
    COOPER, BR
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1995, 32 (05) : 1423 - 1428
  • [47] Structural and Electronic Properties of 4-Bromo-2-(1H-Imidazo[4,5-b]Pyridin-2-yl)Phenol from Density Functional Theory Calculation
    Toh, Pek-Lan
    Char, Jee-Sien
    Sulaiman, Shukri
    Mohamed-Ibrahim, Mohamed-Ismail
    ADVANCED SCIENCE LETTERS, 2017, 23 (11) : 11066 - 11069
  • [48] Excited state intramolecular proton transfer in 2-(2'-hydroxyphenyl)-1H-imidazo[4,5-c]pyridine: effects of solvents
    Balamurali, MM
    Dogra, SK
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 2002, 154 (01) : 81 - 92
  • [49] Synthesis and bioassay of 3-Aryl-1-(pyridin-4-yl)benzo[4,5] imidazo[1,2-d][1,2,4]- triazin-4(3H)-ones as anti-cancer agents
    Thaher, Bassam Abu
    Al-Masri, Ihab
    Wahedy, Kanan
    Morjan, Rami
    Aliwaini, Saeb
    Al Atter, Iman Mahmoud
    Elmabhouh, Aayat Ahmed
    Al Ibwaini, Areej Khaled
    Alkhaldi, Saba Luay
    Qeshta, Basem
    Jacob, Claus
    Deigner, Hans-Peter
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (08) : 1797 - 1810
  • [50] 3-DEAZA-2'-DEOXYADENOSINE - SYNTHESIS VIA 4-(METHYLTHIO)-1H-IMIDAZO[4,5-C]PYRIDINE 2'-DEOXYRIBONUCLEOSIDES AND PROPERTIES OF OLIGONUCLEOTIDES
    SEELA, F
    GREIN, T
    SAMNICK, S
    HELVETICA CHIMICA ACTA, 1992, 75 (05) : 1639 - 1650